| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2866650 | 73 | M | KS | 10/17/2025 |
COVID19 |
MODERNA |
|
Unevaluable event
Unevaluable event
|
Resting pulse 102 vs normal around 65.
Resting pulse 102 vs normal around 65.
|
||||||
| 2866651 | 82 | F | MN | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
na0738 |
Fatigue, Gait disturbance, Urinary incontinence
Fatigue, Gait disturbance, Urinary incontinence
|
patient states she became very fatigued and could barely walk. She also lost all control of her bla...
patient states she became very fatigued and could barely walk. She also lost all control of her bladder overnight
More
|
||||||
| 2866652 | 72 | F | MO | 10/17/2025 |
UNK |
UNKNOWN MANUFACTURER |
U8875AA |
Nausea, Orbital oedema, Pyrexia, Vomiting
Nausea, Orbital oedema, Pyrexia, Vomiting
|
Patient came through our Drive Thru Flu Clinic at approx 11am on Wed 10/15/25. She received a Fluzon...
Patient came through our Drive Thru Flu Clinic at approx 11am on Wed 10/15/25. She received a Fluzone HD Influenza vaccine by one of the nurses, [withheld name], RN, IM in R Deltoid. She states approx 12 hours later, 11 pm, she started having a fever, lasting about 5-6 hours. Emesis x2 through the night. The next morning, Thurs 10/16, she had orbital edema and nausea all day. She has improved today, 10/17, but does still have some edema around her eyes. Recommendations for patient. Use cold compresses on eye area, stay cool and continue Loratadine as directed, and try Diphenhydramine 25mg at bedtime. Keep head elevated. Seek medical treatment/911 if she worsens or starts having breathing difficulties. She is agreeable and is gracious for call to check on her.
More
|
||||||
| 2866653 | 55 | F | IL | 10/17/2025 |
FLU3 |
GLAXOSMITHKLINE BIOLOGICALS |
J5T3B |
Urticaria
Urticaria
|
hives to trunk, upper legs, bilateral arms, face and ears developed evening of 10/15/2025. evaluated...
hives to trunk, upper legs, bilateral arms, face and ears developed evening of 10/15/2025. evaluated by occ med NP. Instructed to take Benadryl and utilize cold compress.
More
|
||||||
| 2866654 | 58 | F | 10/17/2025 |
VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
3G5T3 3G5T3 |
Chills, Injection site erythema, Injection site pain, Injection site pruritus, I...
Chills, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling; Pyrexia
More
|
Patient got the vaccine on 13 th and got fever and chills that day by evening and saw the swelling, ...
Patient got the vaccine on 13 th and got fever and chills that day by evening and saw the swelling, itching , pain and redness on the arm below the shot was given by next day. She came back to pharmacy on 16th morning to show the site. consulted on her and gave cortisone 1% cream to apply on the area for itching and lidoaine 4% cream to apply for pain. Followed up with with her in the afternoon and the swelling and redness went down a lot. she said it doesn't itch her anymore and the pain went down also. Spoke to patient on 10/17. It's getting better, not fully cleared
More
|
|||||||
| 2866655 | 58 | M | MD | 10/17/2025 |
FLU3 FLU3 |
SANOFI PASTEUR SANOFI PASTEUR |
U8827AA UT8770JA |
Extra dose administered, No adverse event; Extra dose administered, No adverse e...
Extra dose administered, No adverse event; Extra dose administered, No adverse event
More
|
Patient received the Fluzone influenza vaccine on 10/8/25. On 10/15/25, he requested to receive the...
Patient received the Fluzone influenza vaccine on 10/8/25. On 10/15/25, he requested to receive the COVID vaccine. However, he was given another dose of the Fluzone influenza vaccine in error. The patient was contacted on 10/16/25 and informed of the error. He denied any adverse side effects and stated he was feeling well.
More
|
||||||
| 2866656 | 48 | F | WI | 10/17/2025 |
FLU3 |
SANOFI PASTEUR |
UT8817KA |
Injection site erythema, Injection site pain, Injection site warmth
Injection site erythema, Injection site pain, Injection site warmth
|
Patient reports she had a flu shot on Wednesday in her left arm and awoke this morning with a patch ...
Patient reports she had a flu shot on Wednesday in her left arm and awoke this morning with a patch of redness on her left upper arm. Patient has never had a reaction to the flu vaccine before. No other stings or bites or anything in the area. The area is warm and somewhat painful
More
|
||||||
| 2866657 | 62 | M | CA | 10/17/2025 |
UNK |
UNKNOWN MANUFACTURER |
flu shot |
Arthralgia, Cough, Eye haemorrhage, Inner ear inflammation, Peripheral swelling
Arthralgia, Cough, Eye haemorrhage, Inner ear inflammation, Peripheral swelling
|
*9/12. cough continue to now.?*10/8. left eye bleeding?*10/10. both the tip of the toe are swelling...
*9/12. cough continue to now.?*10/8. left eye bleeding?*10/10. both the tip of the toe are swelling and pain?10/11, both the inside of the ears were inflamed?10/13. right eye bleeding ?10/14. left knee pain?10/16. right knee pain?
More
|
||||||
| 2866658 | 45 | F | TX | 10/17/2025 |
FLU3 |
SANOFI PASTEUR |
UT8826KA |
Diarrhoea, Dizziness, Dyspnoea, Heart rate increased, Paraesthesia
Diarrhoea, Dizziness, Dyspnoea, Heart rate increased, Paraesthesia
|
The patient called today to report an adverse reaction following administration of the influenza vac...
The patient called today to report an adverse reaction following administration of the influenza vaccine. She received the vaccine on 10/15/25 at 9:13 AM. She reported that symptoms began on 10/16/25 at approximately 1:00 AM. The patient described experiencing symptoms similar to her known allergic reaction to Benadryl, including generalized tingling sensations, rapid heart rate, difficulty breathing, dizziness, and some diarrhea. She stated that the symptoms resolved spontaneously after approximately an hour and a half, and she did not seek emergency care. The following morning, she visited her primary care provider. During the call, the patient requested the name of the vaccine and the manufacturer, and this information was provided. She explained that she wanted this information in order to review the ingredients of the vaccine.
More
|
||||||
| 2866659 | 30 | M | MA | 10/17/2025 |
MENB MNQ PNC20 |
NOVARTIS VACCINES AND DIAGNOSTICS NOVARTIS VACCINES AND DIAGNOSTICS PFIZER\WYETH |
47KS7 Z453D MG7421 |
Dizziness, Epistaxis; Dizziness, Epistaxis; Dizziness, Epistaxis
Dizziness, Epistaxis; Dizziness, Epistaxis; Dizziness, Epistaxis
|
Patient experienced minor nosebleed for 2 days post vaccination. Patient also reports severe lighthe...
Patient experienced minor nosebleed for 2 days post vaccination. Patient also reports severe lightheadedness and dizziness for 1 week with no resolution.
More
|
||||||
| 2866660 | 26 | F | AR | 10/17/2025 |
COVID19 FLU3 |
MODERNA SANOFI PASTEUR |
3052586 U8864AA |
Cold sweat, Hyperhidrosis, Pallor; Cold sweat, Hyperhidrosis, Pallor
Cold sweat, Hyperhidrosis, Pallor; Cold sweat, Hyperhidrosis, Pallor
|
After immunizing the patient at 12:30PM , the patient stated they felt dizzy and lightheaded at appr...
After immunizing the patient at 12:30PM , the patient stated they felt dizzy and lightheaded at approximately 12:32PM, patient was sweating, clammy and pale. We gave patient a cold pack and some cold water to cool her down and she started feeling better. After a few minutes, the patient started feeling worse but did not lose consciousness. We then called EMS. Patient started feeling better when EMS arrived was not as pale or sweating. EMS took her vitals (bp and blood sugar) and they were normal. Patient continued to improve and declined going to hospital.
More
|
||||||
| 2866661 | 66 | M | GA | 10/17/2025 |
FLU3 |
SANOFI PASTEUR |
u8859ba |
Underdose
Underdose
|
Patient was only given half the dose. The other half went out his arm.
Patient was only given half the dose. The other half went out his arm.
|
||||||
| 2866662 | 5 | M | ME | 10/17/2025 |
FLU3 FLU3 |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
4D255 4D255 |
Dyskinesia, Eye movement disorder, Fall, Flushing, Presyncope; Skin discolourati...
Dyskinesia, Eye movement disorder, Fall, Flushing, Presyncope; Skin discolouration, Skin warm, Tachycardia
More
|
Child tolerated injection well. Within 1-2 minute child's eyes looked up and fell over, another...
Child tolerated injection well. Within 1-2 minute child's eyes looked up and fell over, another staff member preventing the child's head from hitting the floor. Very brief jerky movements in arms, skin flushed and warm, dusky green-tinged circumoral coloring. radial pulse tachycardic. Child responded to voice and touch within 5-10 seconds. Child denied symptoms except for not feeling well, but was visibly sluggish and shaky. Approx 15 min total until symptoms resolved with juice and rest. Medical Director consulted via phone with assessment given- likely vasovagal response. Parents contacted personal pediatrician for follow up guidance.
More
|
||||||
| 2866663 | 54 | M | NJ | 10/17/2025 |
COVID19 |
MODERNA |
3052663 |
Borrelia test, HIV test, Helicobacter test, Mechanical urticaria, Urticaria chro...
Borrelia test, HIV test, Helicobacter test, Mechanical urticaria, Urticaria chronic
More
|
Severe chronic urticaria, dermographism, continuing but resolving as of 10/17/2025. Hive outbreak b...
Severe chronic urticaria, dermographism, continuing but resolving as of 10/17/2025. Hive outbreak began on back four days after shot, spread to arms and legs, Multiple rounds of Prednisone is finally bringing the condition under control. Presently showing great improvement, not fully resolved. No other symptoms (fever, fatigue, etc.) before or during this event.
More
|
||||||
| 2866665 | 81 | F | NC | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
NA0739 |
Arthralgia, Mobility decreased, X-ray
Arthralgia, Mobility decreased, X-ray
|
patient reports significant pain in right shoulder and inability to lift right arm; she denies numbn...
patient reports significant pain in right shoulder and inability to lift right arm; she denies numbness or tingling in right arm
More
|
||||||
| 2866666 | 25 | M | HI | 10/17/2025 |
COVID19 COVID19 COVID19 COVID19 |
MODERNA MODERNA MODERNA MODERNA |
041B21A 041B21A 041B21A 041B21A |
Abdominal distension, Alcohol intolerance, Brain fog, Burning sensation, Chest p...
Abdominal distension, Alcohol intolerance, Brain fog, Burning sensation, Chest pain; Exercise tolerance decreased, Fatigue, Gastrooesophageal reflux disease, Histamine intolerance, Histamine level increased; Hot flush, Imaging procedure, Magnetic resonance imaging heart, Magnetic resonance imaging normal, Pain in extremity; Palpitations, Paraesthesia, Poor quality sleep, Pyrexia, Thrombin-antithrombin III complex increased
More
|
Chest pain and palpitations began the night after injections and were especially pronounced for seve...
Chest pain and palpitations began the night after injections and were especially pronounced for several weeks but lingered until treatment. Fever and hot flashes, whole body tingling and burning sensations occurred the night following injection and intermittently until treatment, affecting sleep quality. Poor tolerance for alcohol and exercise, bloating and reflux, histamine intolerance, and chronic fatigue all developed over the following months and remain chronic. Cardiac MRI 13 December 2023 ruled out myocarditis. Additional chronic fatigue and brain fog, as well as intermittent jabbing pains in the extremities, led to getting treated for vaccine injury by clinic starting August 2024, which included 6 months of triple therapy (eliquis, plavix and aspirin) and mast cell stabilizers and antihistamines. This was supplemented with 40 hyperbaric chamber sessions. The treatment reduced most symptoms but did not eliminate them except for the chest pain and jabbing pain in extremities, bringing them to a chronic but manageable level.
More
|
โ | |||||
| 2866667 | 67 | F | WA | 10/17/2025 |
FLU3 PNC20 |
SANOFI PASTEUR PFIZER\WYETH |
UT8794CA MA2488 |
Erythema, Product administered at inappropriate site, Swelling; Erythema, Produc...
Erythema, Product administered at inappropriate site, Swelling; Erythema, Product administered at inappropriate site, Swelling
More
|
pt had swelling and redness, the size of a golfball. Patient feels the vaccine was administered too ...
pt had swelling and redness, the size of a golfball. Patient feels the vaccine was administered too low on the arm.
More
|
||||||
| 2866668 | 60 | M | CA | 10/17/2025 |
RSV |
MODERNA |
3041770 |
Extra dose administered
Extra dose administered
|
Pt received RSV last year 10/23/2024, RSV is only a one time dose.
Pt received RSV last year 10/23/2024, RSV is only a one time dose.
|
||||||
| 2866669 | 0.17 | F | AL | 10/17/2025 |
DTAP HIBV IPV PNC15 RSV RV5 |
GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR SANOFI PASTEUR MERCK & CO. INC. PFIZER\WYETH MERCK & CO. INC. |
JP227 UK304AA YID03P1 Y019380 UK203AA Y020006 |
Injection site rash; Injection site rash; Injection site rash; Injection site ra...
Injection site rash; Injection site rash; Injection site rash; Injection site rash; Injection site rash; Injection site rash
More
|
Patient has a rash on left arm where she received IPV. Patient was prescribed prednisone for the all...
Patient has a rash on left arm where she received IPV. Patient was prescribed prednisone for the allergic reaction.
More
|
||||||
| 2866670 | 9 | F | 10/17/2025 |
FLU3 HEP HEPA IPV TDAP |
SEQIRUS, INC. GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR SANOFI PASTEUR |
406987 9n9py 273h3 y1a212m u8564aa |
Dizziness, Pallor; Dizziness, Pallor; Dizziness, Pallor; Dizziness, Pallor; Dizz...
Dizziness, Pallor; Dizziness, Pallor; Dizziness, Pallor; Dizziness, Pallor; Dizziness, Pallor
More
|
After administering the vaccines patient felt dizzy and looked paled. Both feet elevated, Wet compre...
After administering the vaccines patient felt dizzy and looked paled. Both feet elevated, Wet compress placed on forehead. Fan placed on patient. juice given to patient. Vital signs 98/64, 84, 26 temp 98.6. After 10 mins patient felt better. denies dizziness at this time. Dad given instructions to call EMS if any problems at home.
More
|
|||||||
| 2866671 | 88 | F | IL | 10/17/2025 |
COVID19 FLU3 |
MODERNA SANOFI PASTEUR |
3052731 U8800DA |
Systemic inflammatory response syndrome; Systemic inflammatory response syndrome
Systemic inflammatory response syndrome; Systemic inflammatory response syndrome
|
SIRS, Systematic Inflammatory Response Syndrome
SIRS, Systematic Inflammatory Response Syndrome
|
โ | |||||
| 2866675 | 88 | F | TX | 10/17/2025 |
RSV RSV RSV |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
na na na |
Asthenia, Blood pressure decreased, Constipation, Cough, Dehydration; Dizziness,...
Asthenia, Blood pressure decreased, Constipation, Cough, Dehydration; Dizziness, Dyspnoea, Ear pain, Gait inability, Headache; Heart rate increased, Paraesthesia, Pneumonia, Pyrexia, Tongue discomfort
More
|
FEVER, WEAKNESS, TONGUE ON FIRE, SEVERE EAR PAIN, SHARP PAIN IN HEAD, COUGHING, DIZZINESS, LABORED ...
FEVER, WEAKNESS, TONGUE ON FIRE, SEVERE EAR PAIN, SHARP PAIN IN HEAD, COUGHING, DIZZINESS, LABORED BREATHING, UNABLE TO WALK, TINGLING IN EXTREMITIES, CONSTIPATION, RAPID HEART BEAT, DECREASE IN BLOOD PRESSURE, DEHYDRATION; PATIENT ULTIMATELY TREATED IN HOSPITAL FOR SYMPTOMS BUT CONTRACTED HOSPITAL PNEUMONIA.
More
|
โ | |||||
| 2866677 | 30 | M | MS | 10/17/2025 |
MENB MNQ PNC20 |
NOVARTIS VACCINES AND DIAGNOSTICS NOVARTIS VACCINES AND DIAGNOSTICS PFIZER\WYETH |
47KS7 Z453D MG7421 |
Dizziness, Impaired driving ability; Dizziness, Impaired driving ability; Dizzin...
Dizziness, Impaired driving ability; Dizziness, Impaired driving ability; Dizziness, Impaired driving ability
More
|
Patient stated per phone call that he has been experiencing light headedness and cannot drive since ...
Patient stated per phone call that he has been experiencing light headedness and cannot drive since he had all 3 vaccines administered on 10/9/2025. Patient was 30 years old when he had MenACWY Menveo, MenB Bexsero and Pneumococcal Prevnar20 administered on 10/9/2025.
More
|
||||||
| 2866678 | 7 | M | TX | 10/17/2025 |
FLU3 |
SANOFI PASTEUR |
U8823AA |
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
Auto generated said: Here?s a polished version of what to type for Item 18 ? written in VAERS-appro...
Auto generated said: Here?s a polished version of what to type for Item 18 ? written in VAERS-appropriate language and clear chronological order: Item 18 ? Describe the adverse event(s), treatment, and outcome(s): Patient presented for influenza vaccination. The vaccine ordered in the chart was Fluarix (quadrivalent, standard dose); however, documentation showed the lot number for Flublok (recombinant influenza vaccine) was signed out and administered. When questioned, the medical assistant confirmed that Flublok was given in error. The patient is 7 years old, and Flublok is only indicated for ages 9 years and older. There is no documentation that the parent was notified of the administration error in the chart. Dr was informed and stated she would contact the mother to notify her. Outcome of notification is unknown. No adverse reactions were reported at the time of discovery.
More
|
||||||
| 2866679 | 63 | F | MI | 10/17/2025 |
FLU3 |
SEQIRUS, INC. |
407271 |
Chills, Feeling abnormal, Nervousness, Pain
Chills, Feeling abnormal, Nervousness, Pain
|
After the vaccine the patient went gym, worked out then played bocci ball then came home and had din...
After the vaccine the patient went gym, worked out then played bocci ball then came home and had dinner. A neighbor called and had fallen so patient went over to neighbors to assist. When she came home she felt very weak, shaky, had chills and overall aches. She went to bed and began to feel better the next day. I talked to her today 10/17 and she said she feels fine now. She has had flu shots in the past and never felt like this after so was wondering if this was maybe a bad batch or maybe too much of a dose for her because she isn't very big. Wondering if she had ever had the senior dose before?
More
|
||||||
| 2866681 | 58 | M | IL | 10/17/2025 |
FLU3 FLU3 FLU3 FLU3 |
SANOFI PASTEUR SANOFI PASTEUR SEQIRUS, INC. SEQIRUS, INC. |
407007 407007 |
Back pain, Muscular weakness, Neuralgic amyotrophy; Back pain, Hypoaesthesia, Ma...
Back pain, Muscular weakness, Neuralgic amyotrophy; Back pain, Hypoaesthesia, Magnetic resonance imaging, Muscular weakness, Paraesthesia; Back pain, Muscular weakness, Neuralgic amyotrophy; Back pain, Hypoaesthesia, Magnetic resonance imaging, Muscular weakness, Paraesthesia
More
|
beginning 2 days after vaccination into left arm, right upper back pain lasting 3 days, followed by ...
beginning 2 days after vaccination into left arm, right upper back pain lasting 3 days, followed by right hand/arm weakness, went to neurologist and diagnosed with Parsonage-Turner Syndrome
More
|
||||||
| 2866682 | 66 | M | TX | 10/17/2025 |
FLU3 |
SEQIRUS, INC. |
|
Osteoarthritis, Spinal osteoarthritis, X-ray of pelvis and hip abnormal
Osteoarthritis, Spinal osteoarthritis, X-ray of pelvis and hip abnormal
|
Osteo arthritis, which has since deteriorated to severe. The latest Diagnosis by MD, 10/21/2024, bas...
Osteo arthritis, which has since deteriorated to severe. The latest Diagnosis by MD, 10/21/2024, based on imaging, is recorded as: "Progressive severe bilateral hip joint space narrowing is present with osteophytosis, subchondral sclerosis and cystic changes. Osteopenia is noted. Degenerative changes are present in the spine and sacroiliac joints." Hip replacement (both hips) has since been recommended repeatedly by multiple orthopedic physicians and an Assistant Professor, Joint Reconstruction.
More
|
||||||
| 2866683 | 57 | F | CA | 10/17/2025 |
COVID19 COVID19 COVID19 FLU3 FLU3 FLU3 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR |
NA0587 NA0587 NA0587 U8832AA U8832AA U8832AA |
Decreased appetite, Dizziness, Dysstasia, Fatigue, Gait disturbance; Headache, M...
Decreased appetite, Dizziness, Dysstasia, Fatigue, Gait disturbance; Headache, Mobility decreased, Muscular weakness, Pain, Pyrexia; Tremor; Decreased appetite, Dizziness, Dysstasia, Fatigue, Gait disturbance; Headache, Mobility decreased, Muscular weakness, Pain, Pyrexia; Tremor
More
|
Day after injections, tired, slight fever, loss of appetite, body aches, headaches. Advil helped wit...
Day after injections, tired, slight fever, loss of appetite, body aches, headaches. Advil helped with fever/body aches. By day 5, symptoms are still present and add muscle weakness. Unable to walk up stairs, lift off of chairs, toilet. Unable to lift 24oz filled water bottle above my head. Hand tremors. Day 9, attempted to go shopping, Got dizzy from walking 10+ minutes. Went home and slept. Still no appetite, muscles still weak-difficulty walking and lifting objects, hand tremors. Day 16, was able to go to a restaurant, appetite inreasing a little. Could not walk more than two blocks. Day 25, able to walk longer but not able to climb stairs or get up from a seated position easily, Day 28, able to get up from a seated postion easier but not walk up stairs, Lost 12 lbs in 4weeks.
More
|
||||||
| 2866684 | 65 | M | WY | 10/17/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
75d3a |
Pain in extremity
Pain in extremity
|
Left arm pain every day since the immunization was administered
Left arm pain every day since the immunization was administered
|
||||||
| 2866686 | 58 | M | MO | 10/17/2025 |
COVID19 UNK |
MODERNA UNKNOWN MANUFACTURER |
|
Arthralgia, Migraine, Mobility decreased, Pyrexia, Rash; Arthralgia, Migraine, M...
Arthralgia, Migraine, Mobility decreased, Pyrexia, Rash; Arthralgia, Migraine, Mobility decreased, Pyrexia, Rash
More
|
Rash of raised red weeping blisters on feet hands and arms, especially dense near elbows.. Also low ...
Rash of raised red weeping blisters on feet hands and arms, especially dense near elbows.. Also low fever, migraine, and severe joint pain, especially hands elbows shoulders, toes, and hips. Unable to fully straighten some fingers and both elbows .
More
|
||||||
| 2866687 | 1.17 | M | CA | 10/17/2025 |
DTAP HIBV PNC15 |
SANOFI PASTEUR SANOFI PASTEUR MERCK & CO. INC. |
4CA03C2 UK233AA Z003633 |
Urticaria; Urticaria; Urticaria
Urticaria; Urticaria; Urticaria
|
Patient developed urticaria /hives on his body, arms, legs the day after vaccine was given
Patient developed urticaria /hives on his body, arms, legs the day after vaccine was given
|
||||||
| 2866688 | 61 | F | SC | 10/17/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
B5NJ9 |
Erythema, Pruritus, Swelling
Erythema, Pruritus, Swelling
|
PATIENT REPORTED RED, SWOLLEN, AND ITCHING IN AREA
PATIENT REPORTED RED, SWOLLEN, AND ITCHING IN AREA
|
||||||
| 2866689 | F | WA | 10/17/2025 |
COVID19 FLUX |
PFIZER\BIONTECH UNKNOWN MANUFACTURER |
|
Malaise; Malaise
Malaise; Malaise
|
She felt sick; This is a spontaneous report received from a Nurse from medical information team. A ...
She felt sick; This is a spontaneous report received from a Nurse from medical information team. A female patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (FLU [INFLUENZA VACCINE]), as dose number unknown, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "She felt sick". Additional information: It was reported that her daughter in law also took the two vaccines (COVID and flu) and she felt sick that night but she was fine. . The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.
More
|
|||||||
| 2866690 | 50 | F | CA | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
EW0150 |
Cerebrovascular accident
Cerebrovascular accident
|
Had a reaction like a stroke like event 3 weeks after the second shot; This is a spontaneous report ...
Had a reaction like a stroke like event 3 weeks after the second shot; This is a spontaneous report received from a Consumer or other non HCP. A 55-year-old female patient received BNT162b2 (BNT162B2), on 31Mar2021 as dose 2, single (Lot number: EW0150) at the age of 50 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "hyperreflexia" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE; MANUFACTURER UNKNOWN), for Covid-19 Immunization. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant) with onset Apr2021, outcome "unknown", described as "Had a reaction like a stroke like event 3 weeks after the second shot". Clinical course: The patient had a reaction like a stroke like event 3 weeks after the second shot (Pfizer COVID-19 Vaccine). The patient did not correlate the stroke like event to the vaccine because she would had it 3 weeks before, it never occurred to her that could have a response or reaction, adverse reaction several weeks after the shot, but it was like clockwork 3 weeks and 3 weeks for both of them and when she did a timeline, she realized this is the vaccine and it was so extreme that she really feel like she almost died, it was very.
More
|
||||||
| 2866691 | 69 | F | MD | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
FG3527 |
Headache, Tinnitus
Headache, Tinnitus
|
I had a slight headache every time; I have tinnitus and it gets worse every time I get a covid vacci...
I had a slight headache every time; I have tinnitus and it gets worse every time I get a covid vaccine; This is a spontaneous report received from a Consumer or other non HCP. A 69-year-old female patient received BNT162b2 (BNT162B2), on 08Nov2021 as dose number unknown, single (Lot number: FG3527) at the age of 69 years intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Tinnitus" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE NUMBER UNKNOWN, SINGLE), administration date: 06Apr2021, for COVID-19 IMMUNISATION, reaction(s): "HEADACHE". The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "I had a slight headache every time"; TINNITUS (non-serious), outcome "unknown", described as "I have tinnitus and it gets worse every time I get a covid vaccine". Additional information: Upon reporting for recent vaccine, patient mentioned that she woke up with a headache which has been her reaction to previous covid vaccines. She had first covid shot on 06Apr2021 and had a slight headache every time.
More
|
||||||
| 2866692 | 72 | F | MD | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
HN0477 |
Headache, Tinnitus
Headache, Tinnitus
|
A slight headache every time; Has tinnitus and it gets worse every time the patient gets a COVID vac...
A slight headache every time; Has tinnitus and it gets worse every time the patient gets a COVID vaccine; This is a spontaneous report received from a Consumer or other non HCP. A 72-year-old female patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 24Apr2024 as dose 1, 0.3ml, single (Lot number: HN0477) at the age of 72 years intramuscular, in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: COVID-19 shot, administration date: 06Apr2021, when the patient was 69-year-old, for COVID-19 immunization, reaction(s): "slight headache", "tinnitus"; comirnaty (Lot Number: FG3527, intramuscular, right arm, 0.3ml), administration date: 08Nov2021, when the patient was 69-year-old, for COVID-19 immunization, reaction(s): "slight headache", "tinnitus"; comirnaty original/omicron ba.4-5 (Lot Number: GJ3277, intramuscular, right arm, 0.3ml), administration date: 12Oct2022, when the patient was 70-year-old, for COVID-19 immunization, reaction(s): "slight headache", "tinnitus"; comirnaty omicron xbb.1.5 (Lot Number: HG2282, intramuscular, left arm, 0.3ml), administration date: 09Oct2023, when the patient was 71-year-old, for COVID-19 immunization, reaction(s): "slight headache", "tinnitus". The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "A slight headache every time"; TINNITUS (non-serious), outcome "unknown", described as "Has tinnitus and it gets worse every time the patient gets a COVID vaccine".
More
|
||||||
| 2866693 | F | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Antinuclear antibody positive, Breast mass, Dry skin, Hypersensitivity, Pruritus
Antinuclear antibody positive, Breast mass, Dry skin, Hypersensitivity, Pruritus
|
Itching; Breast lumps; Dry skin; Other allergic reaction; positive ANA; This is a spontaneous report...
Itching; Breast lumps; Dry skin; Other allergic reaction; positive ANA; This is a spontaneous report received from a Consumer or other non HCP from a sales representative. An adult female patient (not pregnant) received BNT162b2 (BNT162B2), in Jan2020 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, manufacturer unknown.), for Covid-19 immunization. The following information was reported: BREAST MASS (non-serious) with onset Jan2020, outcome "recovered with sequelae" (Aug2025), described as "Breast lumps"; DRY SKIN (non-serious) with onset Jan2020, outcome "recovered with sequelae" (Aug2025); PRURITUS (non-serious) with onset Jan2020, outcome "recovered with sequelae" (Aug2025), described as "Itching"; HYPERSENSITIVITY (non-serious) with onset Jan2020, outcome "recovered with sequelae" (Aug2025), described as "Other allergic reaction"; ANTINUCLEAR ANTIBODY POSITIVE (non-serious) with onset Jan2020, outcome "recovered with sequelae" (Aug2025), described as "positive ANA". Additional information: The patient did not receive any other vaccines on the same date as the vaccine(s) for which you are reporting. Patient stated side effects such as itching, breast lumps, and dry skin, and other allergic reactions. Also stated the patient had a positive ANA. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
More
|
||||||||
| 2866694 | 76 | F | CA | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
GJ6738 |
Balance disorder, Fatigue, Tremor
Balance disorder, Fatigue, Tremor
|
Extreme fatigue; developed gradually balance problem; tremor; This is a spontaneous report received ...
Extreme fatigue; developed gradually balance problem; tremor; This is a spontaneous report received from a Consumer or other non HCP. An elderly female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Nov2022 as dose 5 (booster), single (Lot number: GJ6738) at the age of 76 years intramuscular, in arm for covid-19 immunisation. The patient had no relevant medical history. There were no other diagnosed illnesses/medical history/chronic health conditions to report. The patient is not allergic to any previous vaccination, medications, food or other products. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose 1, Location of injection/shot: arm, lot number: EW0150), administration date: 12Apr2021, when the patient was 75-year-old, for Covid-19 immunization, reaction(s): "Extreme fatigue", "developed gradually balance problem", "Tremor"; BNT162b2 (Dose 2, Location of injection/shot: arm, lot number: ER8735), administration date: 04May2021, when the patient was 75-year-old, for Covid-19 immunization, reaction(s): "Surgery to remove cancerous kidney", "Extreme debilitating fatigue, longterm", "couldn't walk at all", "developed gradually balance problem/can't stand for more than a couple of seconds", "Tremor"; BNT162b2 (Dose 3, Location of injection/shot: arm, lot number: FJ1620), administration date: 29Nov2021, when the patient was 75-year-old, for Covid-19 immunization, reaction(s): "extreme debilitating fatigue, long term", "developed gradually balance problem", "Tremor"; BNT162b2 (Dose 4, Location of injection/shot: arm, lot number: FJ4991), administration date: 13May2022, when the patient was 76-year-old, for Covid-19 immunization, reaction(s): "Extreme fatigue", "increasing balance problems/I can't stand for more than a couple of seconds at a time", "Tremor", "gradually decreased walking to 15 mins, then 10 mins, then 5 ending at her door gasping for breath". The following information was reported: FATIGUE (Medically Significant), outcome "not recovered", described as "Extreme fatigue"; BALANCE DISORDER (non-serious), outcome "unknown", described as "developed gradually balance problem"; TREMOR (non-serious), outcome "unknown". The event "extreme fatigue" required physician office visit.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500107080 same patient, different dose and event;
More
|
โ | |||||
| 2866696 | 41 | F | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
NA0587 |
Vaccination site pain
Vaccination site pain
|
Mild injection site pain; This is a spontaneous report received from a Physician. A 41-year-old fem...
Mild injection site pain; This is a spontaneous report received from a Physician. A 41-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 14Oct2025 as dose 1, single (Lot number: NA0587) at the age of 41 years for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LEVOTHYROXINE; ORAL CONTRACEPTIVE NOS. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 14Oct2025, outcome "recovering", described as "Mild injection site pain". Therapeutic measures were not taken as a result of vaccination site pain. No follow-up attempts are possible.
More
|
|||||||
| 2866697 | 38 | F | NY | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
na4452 |
Menstrual disorder
Menstrual disorder
|
started menstruating; This is a spontaneous report received from a Consumer or other non HCP. A 38-...
started menstruating; This is a spontaneous report received from a Consumer or other non HCP. A 38-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 02Oct2025 as dose 1, single (Lot number: na4452) at the age of 38 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Cancer" (unspecified if ongoing); "depression" (unspecified if ongoing); "chronic pain" (unspecified if ongoing). Concomitant medication(s) included: LEXAPRO. The patient also took other concomitant therapy. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunisation. The following information was reported: MENSTRUAL DISORDER (non-serious) with onset 07Oct2025, outcome "recovered" (14Oct2025), described as "started menstruating". Therapeutic measures were not taken as a result of menstrual disorder. Additional information: Patient have no known allergies. Patient started menstruating. She do not have regular periods because of birth control, so this was abnormal and impactful to her life.
More
|
||||||
| 2866698 | F | HI | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Opsoclonus myoclonus
Opsoclonus myoclonus
|
OMAS (opsoclonus-myoclonus-ataxia syndrome); This is a spontaneous report received from a Physician....
OMAS (opsoclonus-myoclonus-ataxia syndrome); This is a spontaneous report received from a Physician. A 77-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing). The patient took rheumatoid arthritis medications. The following information was reported: OPSOCLONUS MYOCLONUS (medically significant), outcome "unknown", described as "OMAS (opsoclonus-myoclonus-ataxia syndrome)". It was unknown if therapeutic measures were taken as a result of opsoclonus myoclonus. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the event opsoclonus myoclonus and the suspect drug BNT162B2 OMICRON (LP.8.1) cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit-risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, ethics committees and investigators, as appropriate.
More
|
|||||||
| 2866699 | F | MA | 10/17/2025 |
RSV |
PFIZER\WYETH |
|
Exposure during pregnancy, Premature delivery
Exposure during pregnancy, Premature delivery
|
Patient delivered premature; This is a spontaneous report received from a Nurse from a sales represe...
Patient delivered premature; This is a spontaneous report received from a Nurse from a sales representative. A female patient (pregnant) received rsv vaccine prot.subunit pref 2v (ABRYSVO), as dose 1, single (Batch/Lot number: unknown) for maternal immunisation. The patient's relevant medical history included: "Drug allergy" (unspecified if ongoing). The patient was 32 weeks pregnant at the event onset. The patient's concomitant medications were not reported. The following information was reported: PREMATURE DELIVERY (non-serious), outcome "recovered", described as "Patient delivered premature". The baby was delivered, delivery date unknown. It was unknown if therapeutic measures were taken as a result of premature delivery. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
More
|
|||||||
| 2866700 | 63 | M | WA | 10/17/2025 |
PNC20 |
PFIZER\WYETH |
|
Influenza, Pain in extremity
Influenza, Pain in extremity
|
Mild flu symptoms; Upper arm soreness; This is a spontaneous report received from a Consumer or othe...
Mild flu symptoms; Upper arm soreness; This is a spontaneous report received from a Consumer or other non HCP. A 63-year-old male patient received pneumococcal 20-valent conjugate vaccine (diphtheria CRM197 protein) (PREVNAR 20), on 15Oct2025 at 14:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 63 years, in right arm for immunisation. The patient's relevant medical history included: "Pre Diabetes" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Congestive Heart Failure" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing). Concomitant medication(s) included: LOSARTIN; CARVEDILOL. The patient did not receive any other vaccines on the same date as the vaccine(s). The patient did not receive any other vaccines within 4 weeks prior to the vaccine(s). The following information was reported: INFLUENZA (non-serious) with onset 16Oct2025, outcome "recovering", described as "Mild flu symptoms"; PAIN IN EXTREMITY (non-serious) with onset 16Oct2025, outcome "recovering", described as "Upper arm soreness". Therapeutic measures were not taken as a result of influenza, pain in extremity. The information on the batch/lot number for pneumococcal 20-valent conjugate vaccine (diphtheria CRM197 protein) will be requested and submitted if and when received.
More
|
||||||
| 2866701 | M | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Body height, Body height increased, Therapeutic response unexpected
Body height, Body height increased, Therapeutic response unexpected
|
used to have eczema/got the COVID-19 shot in 2021, since then he has not experienced eczema/at least...
used to have eczema/got the COVID-19 shot in 2021, since then he has not experienced eczema/at least 5 inches or more taller than most of the people/ thinks those are 2 potential benefits to look into; at least 5 inches or more taller than most of the people in family/thinks those are 2 potential benefits to look into; This is a spontaneous report received from a Consumer or other non HCP from License Party. Other Case identifier(s): AE-021189 (Biontech SE). A 16-year-old male patient received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "used to have eczema/got the COVID-19 shot in 2021, since then he has not experienced eczema/at least 5 inches or more taller than most of the people/ thinks those are 2 potential benefits to look into"; BODY HEIGHT INCREASED (non-serious), outcome "unknown", described as "at least 5 inches or more taller than most of the people in family/thinks those are 2 potential benefits to look into". Additional information: The patient used to have eczema. He got the COVID-19 shot in 2021, since then he has not experienced eczema. The reporter did not treat the patient in the past for eczema due to side effects from available drugs for eczema. It was also reported that the patient is at least 5 inches or more taller than most of the people in the reporter's family and the reporter's wife's family. The reporter thinks those are 2 potential benefits to look into regarding COVID-19 vaccine. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : AE-021189 Biontech SE;US-PFIZER INC-PV202500122833 same reporter/suspect vaccine/event; different patient;
More
|
||||||||
| 2866702 | M | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Therapeutic response unexpected
Therapeutic response unexpected
|
Both of my sons (ages 16 and 8) used to have eczema. They both got the covid-19 shots in 2021, since...
Both of my sons (ages 16 and 8) used to have eczema. They both got the covid-19 shots in 2021, since then they have not experienced eczema.; This is a spontaneous report received from a Consumer or other non HCP from License Party. Other Case identifier(s): AE-021189. An 8-year-old male patient received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "eczema" (not ongoing). The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "Both of my sons (ages 16 and 8) used to have eczema. They both got the covid-19 shots in 2021, since then they have not experienced eczema.". Additional information: Both of the reporter's sons (ages 16 and 8) used to have eczema. They both got the covid-19 shots in 2021, since then they have not experienced eczema. The reporter did not treat sons in the past for eczema due to side effects from available drugs for eczema. 16 years old son is at least 5 inches or more taller than most people in family or wife's family. The reporter thinks those 2 potential benefits to look into regarding Covid-19 vaccine. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : AE-021189 Biontech SE;US-PFIZER INC-PV202500122832 same reporter/suspect vaccine/event; different patient;
More
|
||||||||
| 2866703 | 10/17/2025 |
COVID19 COVID19 COVID19 FLU3 FLU3 FLU3 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR |
|
Abdominal discomfort, Blood pressure measurement, Body temperature, Chills, Hear...
Abdominal discomfort, Blood pressure measurement, Body temperature, Chills, Heart rate; Hypertension, Malaise, Pain in extremity, Pyrexia, Tremor; Vaccination site pain; Abdominal discomfort, Blood pressure measurement, Body temperature, Chills, Heart rate; Hypertension, Malaise, Pain in extremity, Pyrexia, Tremor; Vaccination site pain
More
|
developed did not feel well; I had the shakes/started getting the shakes at the left arm as well as ...
developed did not feel well; I had the shakes/started getting the shakes at the left arm as well as right arm/both started shaking and couldn't stop; stomach was upset; high blood pressure; went to move my arm and it felt like somebody was stabbing me with a knife, it was extremely painful. And arm was still a little sore, but by Sunday i was perfectly fine; pain and fever/extreme pain at the injection site/sore arm/went to move arm and it felt like somebody was stabbing with a knife/extremely painful/ arm really hurt/pain was terrible; chills; fever/later a fever of 101.9 F/had fever of 101.6 F; This is a spontaneous report received from a Consumer or other non HCP from License Party. Other Case identifier(s): 2025SA290218 (Sanofi). Initial information received on 24-Sep-2025 regarding an unsolicited valid non-serious case received from patient. This case involves an unknown age and unknown gender patient who had the shakes/ started getting the shakes at the left arm as well as right arm/both started shaking and could not stop, heart rate wasn't too bad, it was 92 something, stomach was upset, high blood pressure, went to move my arm and it felt like somebody was stabbing me with a knife. it was extremely painful&my arm was still a little sore, but by sunday i was perfectly fine, pain and fever/extreme pain at the injection site/sore arm/went to move arm and it felt like somebody was stabbing with a knife/extremely painful/arm really hurt/pain was terrible, did not feel well, chills and fever/later a fever of 101.9 F/had fever of 101.6 F after receiving Influenza USP trival A-B subvirion NO preservative vaccine [Fluzone] and covid-19 vaccine MRNA. The patient's past vaccination (s) included covid-19 vaccine on 29-JAN-2021, Pfizer BioNTech covid-19 vaccine on 17-FEB-2021, Pfizer BioNTech covid-19 vaccine on 25-SEP-2021, Pfizer BioNTech COVID-19 vaccine on 22-APR-2022, Pfizer BioNTech covid-19 vaccine on 09-SEP-2022, Spikevax XBB.1.5 on 04-OCT-2023, Spikevax XBB.1.5 on 22-MAR-2024, spikevax 2024-2025 (KP.2) on 30-AUG-2024 with Dose 8, and spikevax 2024-2025 (KP.2) on 02-MAR-2025. The patient's past medical history, medical treatments) and family history were not provided. At the time of the event, the patient had ongoing Hypertension in 2013, Arrhythmia in 2013 and Respiration abnormal in 2013. On 12-Sep-2025, the patient received 1 DF (Dosage form) of suspect Influenza USP trival A-B subvirion NO preservative vaccine Suspension for injection (Unknown strength, Lot and expiry date) via Intramuscular route in unknown administration site for Influenza and dose 10 of 1 DF of suspect covid-19 vaccine MRNA Injection (Unknown strength, lot and expiry date) not produced by Sanofi Pasteur via intramuscular route in unknown administration site for covid-19 Prophylaxis. Information on the batch number was requested corresponding to the one at time of event occurrence. On 12-SEP-2025, the patient had the shakes/started getting the shakes at the left arm as well as right arm/both started shaking and could not stop (tremor), stomach was upset (abdominal discomfort), high blood pressure (hypertension), went to move my arm and it felt like somebody was stabbing me with a knife, it was extremely painful. And arm was still a little sore, but by Sunday i was perfectly fine (pain in extremity), pain and fever/extreme pain at the injection site/sore arm/went to move arm and it felt like somebody was stabbing with a knife/extremely painful/arm really hurt/pain was terrible (vaccination site pain), chills and fever/later a fever of 101.9 F/ had fever of 101.6 F (pyrexia) (Latency same day) following the administration of Influenza USP trival A-B subvirion NO preservative vaccine and covid-19 vaccine MRNA. On 13-Sep-2025, the patient developed did not feel well (malaise) (Latency 1 day) following the administration of influenza USP trival A-B subvirion NO preservative vaccine and covid-19 vaccine MRNA. On an unknown date in SEP-2025, the patient developed heart rate was not too bad, it was 92 something (heart rate increased) (unknown latency) following the administration of Influenza USP trival A-B subvirion NO preservative vaccine and covid-19 vaccine MRNA. Relevant laboratory test results included: Body temperature - On 12-Sep-2025: 101.6 F; on 13-Sep-2025: 97.9 F and Heart rate - In September 2025: 92 UNK [92]. Action taken was not applicable. The patient was treated with paracetamol (tylenol) for Vaccination site pain, Pain in extremity and Pyrexia and codeine for Pain in extremity and Vaccination site pain. At time of reporting, the outcome was Recovering / Resolving for the event Vaccination site pain, was Recovered / Resolved on an unknown date Sep-2025 for the event Pain in extremity and was Unknown for other the events.
More
|
|||||||||
| 2866721 | 10/17/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Fungal infection
Fungal infection
|
face has what looks fungal; This non-serious case was reported by a consumer via interactive digital...
face has what looks fungal; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fungal infection in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fungal infection (Verbatim: face has what looks fungal). The outcome of the fungal infection was not reported. It was unknown if the reporter considered the fungal infection to be related to Shingrix. It was unknown if the company considered the fungal infection to be related to Shingrix. Additional Information: GSK Receipt Date: 08-OCT-2025 The patient received Shingrix vaccine and the face had looks fungal it washes away with effaclar, but immediately comes back.
More
|
|||||||||
| 2866722 | F | 10/17/2025 |
RVX |
UNKNOWN MANUFACTURER |
UNK |
Respiratory syncytial virus infection, Vaccination failure
Respiratory syncytial virus infection, Vaccination failure
|
Suspected vaccination failure; ill with RSV; This serious case was reported by a consumer via inter...
Suspected vaccination failure; ill with RSV; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and respiratory syncytial virus infection (Verbatim: ill with RSV). The outcome of the vaccination failure and respiratory syncytial virus infection were not reported. It was unknown if the reporter considered the vaccination failure and respiratory syncytial virus infection to be related to RSV vaccine. The company considered the vaccination failure to be unrelated to RSV vaccine. It was unknown if the company considered the respiratory syncytial virus infection to be related to RSV vaccine. Additional Information: GSK Receipt Date: 10-OCT-2025 This case was reported by a reporter who knew the patient via interactive digital media. The patient was ill with respiratory syncytial virus infection (RSV) despite vaccination was scary. This case was considered as suspected vaccination failure as details of time to onset and laboratory confirmation regarding respiratory syncytial virus infection were unknown at the time of reporting. The batch number was not provided, and we are unable to contact the reporter. This case was linked with US2025AMR131395, reported by same reporter for different patient.; Sender's Comments: A case of Vaccination failure, an unknown time after receiving RSV vaccine, in a female patient. Based on the available information a?possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received. US-GSK-US2025AMR131395:Case for Another girl
More
|
||||||||
| 2866724 | F | OR | 10/17/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Blood glucose, Body temperature, Feeling abnormal, Pyrexia, Therapeutic response...
Blood glucose, Body temperature, Feeling abnormal, Pyrexia, Therapeutic response unexpected
More
|
near normal blood sugars; feeling atrocious; low grade fever; This is a spontaneous report received ...
near normal blood sugars; feeling atrocious; low grade fever; This is a spontaneous report received from a Consumer or other non HCP from medical information team, Program ID. A female patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 15Oct2025 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 1 Diabetic" (ongoing). The patient's concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset Oct2025, outcome "unknown", described as "feeling atrocious"; PYREXIA (non-serious) with onset Oct2025, outcome "unknown", described as "low grade fever"; THERAPEUTIC RESPONSE UNEXPECTED (non-serious) with onset Oct2025, outcome "unknown", described as "near normal blood sugars". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Type 1 diabetic patient stated having consistent blood sugar levels after getting Covid 19 Vaccine since this morning (15Oct2025), despite feeling atrocious and having a low grade fever. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.
More
|
|||||||
| 2866725 | F | NY | 10/17/2025 |
UNK |
UNKNOWN MANUFACTURER |
No batch number |
Dizziness, Gait inability, Malaise
Dizziness, Gait inability, Malaise
|
I could not even walk; Felt extremely sick at night; Feeling very dizzy; This spontaneous case, init...
I could not even walk; Felt extremely sick at night; Feeling very dizzy; This spontaneous case, initially received on 07-Oct-2025, was reported by a non health professional and concerns a female patient. Medical history: unknown Concomitant medication: refer to appropriate section. It was also reported over the counter medicines. Administration of company suspect drug: On 05-Oct-2025, the patient received Fluad (TIV) for Active immunization for the prevention of influenza disease, dose: 0.5 ml, Route of administration: not reported, Anatomical location: not reported, Lot number: No batch number available and will be asked on follow-up. No additional suspect drugs. Adverse reactions/events and outcomes: On 05-Oct-2025, the patient experienced Felt extremely sick at night (outcome: Unknown). On 06-Oct-2025, the patient experienced I could not even walk (outcome: Unknown). On unknown date in Oct-2025, the patient experienced Feeling very dizzy (outcome: Unknown). The patient had taken the Fluad vaccine on Sunday (05-Oct-2025), which was intended for patients over 65 years of age. That night, the patient had felt extremely sick, and the previous day of report had been unable to walk due to feeling very dizzy. As a result, the patient had requested to speak with someone from the research team - a doctor - who could explain why such a dangerous and powerful vaccine was being given to older people. The patient had questioned why something meant to help was causing such effects and had insisted on receiving a call back the same day for a full explanation. (The patient was persistent on having a call back from someone from the research team to have all the explanations.) Fluad (TIV) action taken: Not Applicable Treatment medication: Tylenol Reporter's assessment: The reporter assessed Felt extremely sick at night, Felt extremely sick at night, Feeling very dizzy as seriousness unknown and causality was not provided.; Reporter's Comments: Due to the spontaneous nature of the case, events are considered related for reporting purposes.
More
|